Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Abdominal Radiology
Erschienen in: Abdominal Radiology 6/2017

07.03.2017 | Pictorial Essay

Cholangiocarcinoma: classification, diagnosis, staging, imaging features, and management

verfasst von: Irai S. Oliveira, Aoife Kilcoyne, Jamie M. Everett, Mari Mino-Kenudson, Mukesh G. Harisinghani, Karthik Ganesan

Erschienen in: Abdominal Radiology | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Cholangiocarcinoma is a relatively uncommon malignant neoplasm with poor prognosis. The distinction between extrahepatic and intrahepatic subtypes is important as epidemiological features, biologic and pathologic characteristics, and clinical course are different for both entities. This review study focuses on the role imaging plays in the diagnosis, classification, staging, and post-treatment assessment of cholangiocarcinoma.
Literatur
1.
2.
Saha SK, Zhu AX, Fuchs CS, Brooks GA (2016) Forty-year trend in cholangiocarcinoma incidence in the U.S.: intrahepatic disease in the rise. The Oncologist 21:594–599CrossRefPubMedPubMedCentral
3.
Nakanuma Y, Sato Y, Harada K, et al. (2010) Pathological classification of intrahepatic cholangiocarcinoma based on a new concept. World J Hepatol 2(12):419–427CrossRefPubMedPubMedCentral
4.
Yamamoto M, Takasaki K, Yoshikawa T, Ueno K, Nakano M (1998) Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma? J Surg Oncol 69(3):162–167CrossRefPubMed
5.
Sasaki A, Aramaki M, Kawano K, et al. (1998) Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment. Br J Surg 85(9):1206–1209CrossRefPubMed
6.
Japan LCSGo (1997) Classification of primary liver cancer. Tokyo: Kanehara
7.
Craig JRPR, Edmonson HA (1989) Tumors of the liver and intrahepatic bile ducts. Atlas of Tumor Pathology: Washington, DC, pp 171–179
8.
Odze RD, Goldblum JR (2014) Odze and Goldblum surgical pathology of the GI tract, liver, biliary tract and pancreas. Berlin: Elsevier Health Sciences
9.
Mounajjed T, Chandan VS, Torbenson MS (2015) Surgical pathology of liver tumors. New York: Springer International PublishingCrossRef
10.
S-i Aishima, Asayama Y, Taguchi K-i, Sugimachi K, Shirabe K, Shimada M, Sugimachi K, Tsuneyoshi M (2002) The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma. Mod Pathol 15(11):1181–1190CrossRefPubMed
11.
12.
Hamada S, Satoh K, Hirota M, et al. (2011) Calcium-binding protein S100P is a novel diagnostic marker of cholangiocarcinoma. Cancer Sci 102(1):150–156CrossRefPubMed
13.
Kakar S, Gown AM, Goodman ZD, Ferrell LD (2007) Best practices in diagnostic immunohistochemistry: hepatocellular carcinoma versus metastatic neoplasms. Arch Pathol Lab Med 131(11):1648–1654PubMed
14.
Nagorney DM, Donohue JH, Farnell MB, Schleck CD, Ilstrup DM (1993) Outcomes after curative resections of cholangiocarcinoma. Arch Surg 128(8):871–878CrossRefPubMed
15.
Edge S, Byrd D, Compton C, et al. (2010) American Joint Committee on Cancer AJCC cancer staging manual. Ann Surg Oncol 17(6):1471–1474CrossRefPubMed
16.
Roayaie S, Guarrera JV, Michele QY, et al. (1998) Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. J Am Coll Surg 187(4):365–372CrossRefPubMed
17.
Jiao Y, Pawlik TM, Anders RA, et al. (2013) Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas. Nat Genet 45(12):1470–1473CrossRefPubMedPubMedCentral
18.
Isa T, Tomita S, Nakachi A, et al. (2001) Analysis of microsatellite instability, K-ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma. Hepato-gastroenterology 49(45):604–608
19.
Borger DR, Tanabe KK, Fan KC, et al. (2012) Frequent mutation of isocitrate dehydrogenase (IDH) 1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. The Oncologist 17(1):72–79CrossRefPubMed
20.
21.
Geynisman DM, Catenacci DV (2012) Toward personalized treatment of advanced biliary tract cancers. Discov Med 14(74):41–57PubMed
22.
23.
Zhang F, Chen XP, Zhang W, et al. (2008) COmbined Heaptocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochecmical and double-fluorescence immunostaining evidence. Histopathology 52(2):224–232CrossRefPubMed
24.
The Liver Cancer Study Group of Japan (1989) The general rules for the clinical and pathological study of primary lliver cancer. Jpn J Surg 19:98–129CrossRef
25.
Fowler KJ, Sheybani A, Parker RA III, et al. (2013) Combined hepatocellular and cholangiocarcinoma (Biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI. AJR 201:332–339CrossRefPubMed
26.
Edmonson HA, Washington DC, Clemett AR. Tumors of the liver and intrahepatic bile ducts: atlas of tumor pathology, sec 7, fasc. 25 Armed Forces Institute of Pathology,. [Cross Reference] Carcinoma of the major bile ducts2000. 894-903 p.
27.
28.
Blechacz B, Komuta M, Roskams T, Gores GJ (2011) Clinical Diagnosis and Staging of Cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 8(9):512–522CrossRefPubMedPubMedCentral
29.
Farges O, Fuks D, Le Treut YP, et al. (2011) AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma. Cancer 117:2170–2177CrossRefPubMed
30.
Yamasaki S (2003) Intrahepatic cholangiocarcinoma: macroscopyc type and stage classification. J Hepatobiliary Pancreat Surg 10(4):288–291CrossRefPubMed
31.
DeOliveira ML, Cunningham SC, Cameron JL, et al. (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245(5):755–762CrossRefPubMedPubMedCentral
32.
Khan SA, Davidson BR, Goldin RD, et al. (2012) Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut 61(12):1657–1669CrossRefPubMed
33.
Tsao JI, Nimura Y, Kamiya J, et al. (2000) Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience. Ann Surg 232(2):166–174CrossRefPubMedPubMedCentral
34.
35.
Lee HY, Kim SH, Lee JM, et al. (2006) Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology. 239(1):113–121CrossRefPubMed
36.
Hong SM, Presley AE, Stelow EB, Frierson HF Jr, Moskaluk CA (2006) Reconsideration of the histologic definitions used in the pathologic staging of extrahepatic bile duct carcinoma. Am J Surg Pathol. 30(6):744–749CrossRefPubMed
37.
Hong SM, Kang GH, Lee HY, Ro JY, Nishi M, Omori Y, Okabayashi T, Yamamoto J, Kosuge T, Shimada K, Yamasaki S, Takayama T, Makuuchi M. Smooth muscle distribution in the extrahepatic bile duct: histologic and immunohistochemical studies of 122 cases. Am Pathol 24 Cross ref Miwa Research Society for Gastric Cancer JRSGC Japanese classification of gastric carcinoma Kanehara Tokyo Cross ref A new staging system for massforming intrahepatic cholangiocarcinoma analysis of preoperative and postoperative variables Cancer 23742383. 2001;92(9 SRC— GoogleScholar):660–7
38.
Jarnagin WR, Fong Y, DeMatteo RP, et al. (2001) Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234(4):507–517CrossRefPubMedPubMedCentral
39.
Honickman SP, Mueller PR, Wittenberg J, et al. (1983) Ultrasound in obstructive jaundice: prospective evaluation of site and cause. Radiology 147(2):511–515CrossRefPubMed
40.
Neumaier CE, Bertolotto M, Perrone R, et al. (1995) Staging of hilar cholangiocarcinoma with ultrasound. J Clin Ultrasound 23(3):173–178CrossRefPubMed
41.
Eloubeidi MA, Chen VK, Jhala NC, et al. (2004) Endoscopic ultrasound-guided fine needle aspiration biopsy of suspected cholangiocarcinoma. Clin Gastroenterol Hepatol 2(3):209–213CrossRefPubMed
42.
Zandrino F, Benzi L, Ferretti ML, et al. (2002) Multislice CT cholangiography without biliary contrast agent: technique and initial clinical results in the assessment of patients with biliary obstruction. Eur Radiol 12(5):1155–1161CrossRefPubMed
43.
Ahmetoglu A, Kosucu P, Kul S, et al. (2004) MDCT cholangiography with volume rendering for the assessment of patients with biliary obstruction. Am J Roentgenol 183(5):1327–1332CrossRef
44.
Yoon HJ, Kim YK, Jang KT, et al. (2013) Intraductal papillary neoplasm of the bile ducts: description of MRI and added value of diffusion-weighted MRI. Abdom Imaging 38(5):1082–1090CrossRefPubMed
45.
46.
47.
48.
49.
50.
51.
Seo S, Hatano E, Higashi T, et al. (2008) Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis, P-glycoprotein expression, and recurrence after resection in mass-forming intrahepatic cholangiocarcinoma. Surgery 143(6):769–777. doi:10.​1016/​j.​surg.​2008.​01.​010 CrossRefPubMed
52.
53.
Wernecke K, Henke L, Vassallo P, et al. (1992) Pathologic explanation for hypoechoic halo seen on sonograms of malignant liver tumors: an in vitro correlative study. AJR Am J Roentgenol 159(5):1011–1016CrossRefPubMed
54.
Yoshida Y, Imai Y, Murakami T, et al. (1999) Intrahepatic cholangiocarcinoma with marked hypervascularity. Abdom Imaging 24(1):66–68CrossRefPubMed
55.
Nakanuma Y (2010) A novel approach to biliary tract pathology based on similarities to pancreatic counterparts: is the biliary tract an incomplete pancreas? Pathol Int 60(6):419–429CrossRefPubMed
56.
Nakanuma Y, Harada K, Sasaki M, Sato Y (2014) Proposal of a new disease concept “biliary diseases with pancreatic counterparts”. Anatomical and pathological bases. Histol Histopathol 29(1):1–10PubMed
57.
Kawakatsu M, Vilgrain V, Zins M, et al. (1997) Radiologic features of papillary adenoma and papillomatosis of the biliary tract. Abdom Imaging 22(1):87–90CrossRefPubMed
58.
Gonda TA, Glick MP, Sethi A, et al. (2012) Polysomy and p16 deletion by fluorescence in situ hybridization in the diagnosis of indeterminate biliary strictures. Gastrointest Endosc 75(1):74–79CrossRefPubMed
59.
Deshpande V, Konstantinidis IT, Castillo CF, et al. (2016) Intra-pancreatic distal bile duct carcinoma is morphologically, genetically, and clinically distinct from pancreatic ductal adenocarcinoma. J Gastrointest Surg . doi:10.​1007/​s11605-016-3108-0 PubMed
60.
Poggi G, Amatu A, Montagna B, et al. (2009) OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma. Cardiovasc Interv Radiol 32(6):1187–1192CrossRef
61.
Ruys AT, van Haelst S, Busch OR, et al. (2012) Long-term survival in hilar cholangiocarcinoma also possible in unresectable patients. World J Surg 36:2179–2186CrossRefPubMedPubMedCentral
62.
Tan JCC, Coburn NG, Baxter NN, Kiss A, Law CHL (2008) Surgical management of intrahepatic cholangiocarcinoma–a population-based study. Ann Surg Oncol 15(2):600–608CrossRefPubMed
63.
Shaib YH, Davila JA, Henderson L, McGlynn KA, El-Serag HB (2007) Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the united states: a population-based study. J Clin Gastroenterol 41(10):911–917CrossRefPubMed
64.
Nakeeb A, Tran KQ, Black MJ, et al. (2002) Improved survival in resected biliary malignancies. Surgery 132(4):555–563 (discission 63)CrossRefPubMed
65.
Meyer CG, Penn I, James L (2000) Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 69(8):1633–1637CrossRefPubMed
66.
De Vreede I, Steers JL, Burch PA, et al. (2000) Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transplant 6(3):309–316CrossRef
67.
Thongprasert S (2005) The role of chemotherapy in cholangiocarcinoma. Ann Oncol 16(Suppl 2):93–96
68.
Vauthey JN, Blumgart LH (1994) Recent advances in the management of cholangiocarcinomas. Semin Liver Dis 14(2):109–114CrossRefPubMed
69.
Chari RS, Rose BD, Wellesley MA. Treatment of cholangiocarcinoma II 2003.
Metadaten
Titel
Cholangiocarcinoma: classification, diagnosis, staging, imaging features, and management
verfasst von
Irai S. Oliveira
Aoife Kilcoyne
Jamie M. Everett
Mari Mino-Kenudson
Mukesh G. Harisinghani
Karthik Ganesan
Publikationsdatum
07.03.2017
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 6/2017
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-017-1094-7

Weitere Artikel der Ausgabe 6/2017

Abdominal Radiology 6/2017 Zur Ausgabe

Classics in Abdominal Imaging

Perirenal fluid collection in renal parenchymal disease: the kidney sweat sign

OriginalPaper

Measuring the apparent diffusion coefficient in primary rectal tumors: is there a benefit in performing histogram analyses?

Classics in Abdominal Imaging

Tennis ball sign: a CT sign of acute aortic dissection

OriginalPaper

Aorta-Lesion-Attenuation-Difference (ALAD) on contrast-enhanced CT: a potential imaging biomarker for differentiating malignant from benign oncocytic neoplasms

OriginalPaper

Magnetic resonance elastography in the assessment of hepatic fibrosis: a study comparing transient elastography and histological data in the same patients

OriginalPaper

CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma

Neu im Fachgebiet Radiologie

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise